FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 41 filers reported holding FUSION PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $30,009,820 | +269.6% | 3,122,770 | 0.0% | 0.60% | +248.3% |
| Q3 2023 | $8,119,202 | -44.3% | 3,122,770 | 0.0% | 0.17% | -34.8% |
| Q2 2023 | $14,583,336 | +23.9% | 3,122,770 | 0.0% | 0.26% | +14.3% |
| Q1 2023 | $11,772,843 | +15.9% | 3,122,770 | -3.2% | 0.23% | +19.1% |
| Q4 2022 | $10,158,026 | +4.6% | 3,224,770 | 0.0% | 0.19% | +7.8% |
| Q3 2022 | $9,707,000 | +20.9% | 3,224,770 | 0.0% | 0.18% | +23.3% |
| Q2 2022 | $8,030,000 | -68.0% | 3,224,770 | 0.0% | 0.15% | -64.0% |
| Q1 2022 | $25,056,000 | +86.3% | 3,224,770 | 0.0% | 0.41% | +134.7% |
| Q4 2021 | $13,447,000 | -47.3% | 3,224,770 | 0.0% | 0.17% | -38.4% |
| Q3 2021 | $25,540,000 | -2.0% | 3,224,770 | 0.0% | 0.28% | +6.4% |
| Q2 2021 | $26,056,000 | -24.6% | 3,224,770 | 0.0% | 0.26% | -18.3% |
| Q1 2021 | $34,570,000 | -8.8% | 3,224,770 | 0.0% | 0.32% | -2.7% |
| Q4 2020 | $37,891,000 | -2.2% | 3,224,770 | 0.0% | 0.33% | -31.8% |
| Q3 2020 | $38,762,000 | -31.2% | 3,224,770 | 0.0% | 0.49% | -38.6% |
| Q2 2020 | $56,337,000 | – | 3,224,770 | – | 0.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,502,425 | $39,994,000 | 10.54% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,670,516 | $44,120,000 | 8.88% |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,551,794 | $30,673,000 | 0.55% |
| Orbimed Advisors | 3,224,770 | $38,762,000 | 0.49% |
| Perceptive Advisors | 2,235,983 | $26,877,000 | 0.39% |
| CLOUGH CAPITAL PARTNERS L P | 402,800 | $4,842,000 | 0.35% |
| Rock Springs Capital Management LP | 947,541 | $11,389,000 | 0.29% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 972,046 | $11,684,000 | 0.28% |
| CANADA PENSION PLAN INVESTMENT BOARD | 3,116,966 | $37,466,000 | 0.07% |
| Woodline Partners LP | 76,093 | $915,000 | 0.03% |